| Literature DB >> 25412786 |
John B Kelly1, Peter Foley2, Bruce E Strober3.
Abstract
For patients with moderate to severe psoriasis, there is a large range of variably effective and safe oral, systemic medications. With appropriate monitoring, these therapies may be used as either monotherapy or in combination with other therapies. Newer drugs in the research pipeline hold significant promise.Entities:
Keywords: Acitretin; Apremilast; Cyclosporine; Methotrexate; Mycophenolate mofetil; Psoriasis; Tofacitinib
Mesh：
Substances：
Year: 2015 PMID： 25412786 DOI： 10.1016/j.det.2014.09.008
Source DB: PubMed Journal: Dermatol Clin ISSN： 0733-8635 Impact factor: 3.478